Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateTimeSourceHeadlineSymbolCompany
02/19/20167:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Promotion of Deborah A. Thomas, Ph.D., to Senior Vice President, Regulatory Affairs, Quali...NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/18/20166:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/16/20164:08PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/16/20162:40PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/12/20164:13PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
02/10/20162:37PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/07/20164:24PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/04/20167:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces European Medicines Agency Validates Marketing Authorization Application for Vosaroxin in AM...NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/28/20151:58PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/22/20154:40PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/21/20154:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/21/20154:05PMGlobeNewswire Inc.Sunesis Announces Closing of $26 Million Offering of Securities and Exercise of Underwriter’s Over-Allotment OptionNASDAQ:SNSSSunesis Pharmaceuticals Inc
12/17/20155:23PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/17/20155:17PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/16/20155:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/16/20158:20AMGlobeNewswire Inc.Sunesis Announces Pricing of $25 Million Offering of SecuritiesNASDAQ:SNSSSunesis Pharmaceuticals Inc
12/16/20158:18AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/16/20158:17AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/08/20157:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Submission of a Marketing Authorization Application for Vosaroxin for the Treatment of Acut...NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/07/20157:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of Positive Results From MD Anderson Sponsored Trial in AML at ASH Annual Meet...NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/06/20157:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of Results From Washington University Sponsored Phase 1/2 Trial of Vosaroxin i...NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/03/20157:00AMGlobeNewswire Inc.Sunesis Partners With Clinigen Group to Initiate a Compassionate Use Program for Patients With Relapsed or Refractory Acute M...NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/01/20157:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces First Patient Treated in Indiana University Pilot Study of Vosaroxin and Cytarabine in Adul...NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/30/20157:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces European Patent Covering Vosaroxin Combination Use in AML and Other Hematologic Malignancie...NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/27/20155:21PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/09/20157:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Presents Preclinical Data From Its BTK and PDK1 Inhibitor Programs at the AACR-NCI-EORTC Internationa...NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/05/20155:58PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/05/20159:27AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentations at ASH Annual MeetingNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/05/20158:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/05/20157:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Third Quarter 2015 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS